Figure 1: A schematic illustration of the constructions ... Size selection of DNA fragments is crucial. The Roche 454 Titanium platform is able to sequence, on average, 500 bp, and the selected ...

Roche ($RHHBY) is taking another step toward reducing its focus on gene sequencing by shutting down 454 Life Sciences, a subsidiary in the space it acquired from ...

Roche and CuraGen have announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in ...

For further information, please visit our website at www.roche.com. 454 Life Sciences Corporation develops and commercializes novel instrumentation for high-throughput DNA sequencing. Specific ...

For more information on 454 Sequencing Systems, visit www.454.com. Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals ...

The 454 Sequencing Center offers sequencing services directly to customers on a fee for service basis. 454 Life Sciences is a business unit of Roche Applied Science, a division of Roche Diagnostics.

It’s bonkers.” Roche is not a newcomer to the sequencing space: the company bought Jonathan Rothberg’s 454 in 2007 for $140 million. 454 had just announced the completion of Jim Watson’s ...

For Roche, the deal marks an endorsement of 454's sequencing technology. Roche and 454 signed a collaboration pact in May of 2005 which designated Roche Diagnostics as the worldwide distributor of ...

Roche announced today the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer Sets for comprehensive genetic variation detection in four key human genes ...

Based on next generation 454 Sequencing Systems from Roche, the study aims to characterize selected genes in individuals with a wide range of hematological malignancies. The consortium of 26 ...

Complete the form below to unlock access to ALL audio articles. Under the terms of the agreement, Roche will pay 454 Life Sciences’ shareholders USD 140 million in cash. In addition to the payment ...